ESMO Congress 2026

October 23–27, 2026 · Madrid · 176 items

Madrid floor. One post is one item; several people on the same trial or drug become a heat probe. The floor is paged by day; prelude discussion sits on the prelude board. Abstracts are linked, not reprinted, and other people's slides are not posted.

TodayOct 23Fri

Friday · 30 items

05:50
Krishan Jethwa@KrishanJethwaScore6060
🚨ARION PRODIGE 67🚨 Locally Advanced Esophagus Cancer (adeno or squam) n=112 Randomized CRT (50 Gy/25 Fx + FOLFOX) +/- concurrent and adjuvant durvalumab (total 12 m) No SS diffe…
Same topic ARION · 2 people durvalumabHeat 00 likes0 replies0 reposts
05:30
Dr Amol Akhade@SuyogCancerScore6060
The benifit is same as if you give neo adjuvant pembrolizumab? - cross trial comparisons- Will this hold true if Pembrolizumab is given neoadjuvant in control arm ? We don't know…
Same topic pembrolizumab · 2 peopleHeat 00 likes0 replies0 reposts
05:25
Jacob Plieth@JacobPliethScore6060
@Sanctuary_Bio For #Esmo26 it's just bad luck. Not really their fault that someone leaked. Embargoes break all the time. But I can't imagine Asco or Ash reacting this strongly.
Heat 00 likes0 replies0 reposts
05:25
⛏🅾️Ⓜ️💣@tom_the_bomb__Score6060
#AVCT trolls come and go. Prof Banerji, on the other hand, was principal investigator when @avacta’s AVA6000 trial began in 2021. 5+ years on, he’s still presenting data on preCI…
AVA6000 #AVCTHeat 00 likes0 replies0 reposts
05:23
Nicolò Battisti, MD@nicolobattistiScore6060
Older adults at #ESMO26: MOIO (LBA10) on 3-monthly checkpoint inhibitors, TOP-1 (545RO) on omitting RT in older women with ER+ breast cancer, B-42 (LBA24) on extended letrozole, …
MOIO LBA10 545RO LBA24 4761P EV-302 #GERIATRICONCOLOGYHeat 00 likes0 replies0 reposts
05:20
Daniel Ghinn@creationdanielScore6060
Right now there's growing anticipation among HCPs for @NovartisCancer NATALEE trial 6-year breast cancer survival results due to be presented at #ESMO26, according to @CREATION Int…
Same topic NATALEE · 4 peopleHeat 00 likes0 replies0 reposts
05:20
CancerTherapyAdvisor@CancerTherAdvsrScore6060
Beginning tomorrow, investigators will present their latest research at the ESMO Congress 2026 in Madrid! #ESMO2026 @myESMO 🔗 For a preview of what we'll be covering, including …
Heat 00 likes0 replies0 reposts
05:19
Shilpa Gupta@shilpaoncScore6060
After a busy day in clinic, on my way to @myESMO #ESMO2026 in Madrid! Excited to present our research, learn about the latest advances in GU cancers, reconnect with friends and co…
Heat 00 likes0 replies0 reposts
05:13
Herbert Loong, MBBS, FASCO@herbloongScore6060
Welcome to Madrid! 🇪🇸 @ManuPalmerini and I are looking forward to bringing you updated #sarcoma insights from @myESMO #ESMO26. Have a good night’s rest and see you all bright and…
#SARCOMAHeat 00 likes0 replies0 reposts
05:10
Dr. Estela Rodriguez@LatinamdScore6060
Looking forward to the presentation and discussion. #LBA1 Phase 3 INTerpath-001 trial results at #ESMO26 👉🏽The Kaplan-Meir curves don’t always tell the whole story. Side effects, …
Same topic INTERPATH-001 · 11 people LBA1 #LBA1Heat 11 like0 replies0 reposts
05:06
FirstWord Pharma@fwpharmaScore6060
Moderna shares slide after leaked data for Merck & Co.-partnered cancer vaccine $MRNA $MRK #ESMO2026
Heat 00 likes0 replies0 reposts
05:04
Jacob Plieth@JacobPliethScore6060
#Esmo26 pushing the nuclear button: no further embargoed material being given; prior embargoed material being pulled. You think they're pissed off about the $MRNA breach?
Heat 00 likes0 replies0 reposts
05:02
Jacob Plieth@JacobPliethScore6060
$MRNA $MRK #Esmo26
Heat 00 likes0 replies0 reposts
05:00
Dr. Estela Rodriguez@LatinamdScore6060
🤷🏽‍♀️Proof that the market is irrational. This now officially released Merck/Moderna cancer vaccine (mRNA-457) results from a Phase 3 study of 1,100 pts w high-risk melanoma to …
Heat 00 likes0 replies0 reposts
05:00
Udhayvir Grewal@UGrewalMDScore6060
Watch me and my buddies @GIMedOnc and @TimothyJBrownMD discuss what all we’re looking forward to the most in GI oncology abstracts at #ESMO26 @TheGutOncLab
Heat 00 likes0 replies0 reposts
05:00
CancerNetwork®@CancerNetwrkScore6060
🚨6 breast cancer trials to watch at #ESMO26 from leading voices including @ErikaHamilton9 @HundalJasmin and Nusrat Jahan, MD 🔗 #BCSM @myESMO
Heat 10 likes0 replies1 repost
04:58
Jacob Plieth@JacobPliethScore6060
No idea if this is why $MRNA is off 17%, or if it's just because ph3 data have waned from ph2, but this is a smart take #Esmo26 $MRK
Heat 00 likes0 replies0 reposts
04:52
Ruben Sebastian@RubenSebas_Score6060
Long awaited results from INTerpath-001, the first Phase 3 trial to demonstrate efficacy of a personalized mRNA therapy! Intismeran met key endpoints in melanoma $MRNA $MRK A pi…
Same topic INTERPATH-001 · 11 people METHeat 00 likes0 replies0 reposts
04:50
NYU Grossman School of Medicine@nyugrossmanScore6060
At #ESMO26, our oncology experts will present on investigational immunotherapy, gastrointestinal cancers, non-metastatic lung cancer, and other thoracic malignancies. See the full…
Heat 00 likes0 replies0 reposts
04:49
City of Hope@cityofhopeScore6060
Attending #ESMO26? Join @cityofhope for a meet-and-greet with @montypal, Clinical Trials Medical Director of the Comprehensive Cancer Center and Co-director of the Kidney Cancer Pr…
Heat 00 likes0 replies0 reposts
04:48
Vir Biotechnology@Vir_BiotechScore6060
We're joining the global oncology community at #ESMO26 to advance progress for people living with cancer. Leveraging our expertise in immunology, we're advancing a clinical and pre…
#TCESHeat 00 likes0 replies0 reposts
04:45
Timothée Olivier, MD@Timothee_MDScore6060
#ESMO26 tomorrow the 6-y survival results of the NATALEE trial will be presented in Madrid, 2:25 pm trial = 3 years adjuvant ribociclib in patients with HR+ HER2- early breast can…
Same topic NATALEE · 4 people ribociclib HER2Heat 00 likes0 replies0 reposts
04:37
Jose Fernando Moura, PhD@FernandoOncoScore6060
My @ChatGPT preview for DeLLphi 305 OS @IASLC @GBOT_Alerta @NarjustFlorezMD @BalazsHalmosMD @StephenVLiu @lungoncdoc #ESMO26 @myESMO Let’s vote More or Less ?
Heat 00 likes0 replies0 reposts
04:35
Nicholas Hornstein@GIMedOncScore6060
#ESMO26 starts tomorrow! @TimothyJBrownMD @UGrewalMD and I went through the GI abstracts we think are most likely to change practice by Monday. If you're looking for a quick lis…
Heat 00 likes0 replies0 reposts
04:31
Jacob Plieth@JacobPliethScore6060
Didn't take long for the first #Esmo26 embargo breach then. Another frisson: the clocks change in Europe (but not in the US) on Saturday night. Enjoy those embargoes!
Heat 00 likes0 replies0 reposts
04:28
Angela Lamarca@DrAngelaLamarcaScore6060
Great catching up this afternoon on the many ongoing #academic trials and research projects in #GastrointestinalCancer ahead of @myESMO #ESMO26 with the #ENGIC group @GrupoTTD rep…
#ACADEMIC #GASTROINTESTINALCANCER #ENGICHeat 00 likes0 replies0 reposts
04:26
Angela Lamarca@DrAngelaLamarcaScore6060
Ready to report on everything that will be happening Check your topic of interest and follow us! #ESMOAmbassadors #ESMO26 @myESMO @rachnatshroff forever in our hearts 💚
Heat 00 likes0 replies0 reposts
04:15
OncLive.com@OncLiveScore6060
🔬 GU cancer data to watch at #ESMO26: @MattGalsky and @PrafulRavi1 spotlight VOLGA, DASL-HiCaP, and key bladder cancer studies ahead of Madrid. Explore the preview: #GUOncology
Same topic VOLGA · 6 people DASL-HICAP #GUONCOLOGYHeat 00 likes0 replies0 reposts
04:12
Inhibrx Biosciences, Inc.@inhibrxScore6060
Inhibrx is heading to #ESMO2026, where data from the primary analysis of the phase 2 HexAgon-HN study evaluating ordastobart (INBRX-106) will be presented. 📅 Oct. 25 | 8:30–8:30–8…
Heat 00 likes0 replies0 reposts
04:05
Pablo Jiménez@PaulJiLScore6060
@OncoAlert @brunolarvol @adamfeuerstein An alleged third-party leak of the top plenary presentation of the #interpath-001 at #ESMO2026 . Source still unknown. #Intismeran autoge…
Same topic INTERPATH-001 · 11 people #INTERPATH-001 #INTISMERAN #MELANOMA #PRACTICECHANGINGHeat 00 likes0 replies0 reposts